Quantum Leap

Quantum Leap Healthcare Collaborative is a U.S.-based nonprofit clinical research organization that designs and operates adaptive, biomarker-driven platform trials intended to accelerate personalized medicine, especially in oncology. The organization is best known for the I-SPY family of breast cancer trials and the RECAST DCIS platform study, and it also supports trial matching, biomarker integration, and patient-centered research operations. QLHC acts as study sponsor and operator rather than as a traditional therapeutic developer, partnering with biopharma companies, academic investigators, regulators, and technology vendors to evaluate investigational agents and diagnostics in shared trial infrastructure. The group also developed OneSource, an EHR-integrated electronic data capture approach aimed at streamlining clinical research workflows. Overall, QLHC sits at the intersection of clinical trial innovation, precision oncology, and research-enabling health technology.